C12N 2760/20021
Viruses as such
Official title: Viruses as such, e.g. new isolates, mutants or their genomic sequences
C12N2760/20021 (Viruses as such) appears on 17 US grants and 23 published applications in this corpus.
Search patents in C12N- Granted patents
- 17
- Published applications
- 23
- Assignees
- 15
- Inventors
- 25
- Latest grant
- 25 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 1 |
| 2015 | 1 | 3 |
| 2016 | 1 | 2 |
| 2017 | 0 | 0 |
| 2018 | 2 | 1 |
| 2019 | 1 | 1 |
| 2020 | 1 | 2 |
| 2021 | 2 | 3 |
| 2022 | 1 | 1 |
| 2023 | 1 | 2 |
| 2024 | 2 | 1 |
| 2025 | 2 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods of detection and removal of rhabdoviruses from cell lines25 Nov 2025US 12,479,891 B2Takeda Vaccines, Inc.
- Recombinant oncolytic virus8 Jul 2025US 12,351,812 B2Georgia State University Research Foundation, Inc.
- Methods of detection and removal of rhabdoviruses from cell lines25 Jun 2024US 12,018,052 B2Takeda Vaccines, Inc.
- Methods of detection and removal of rhabdoviruses from cell lines11 Jun 2024US 12,006,341 B2Takeda Vaccines, Inc.
- Compositions and methods for glioblastoma treatment23 May 2023US 11,654,192 B2Children's Hospital of Eastern Ontario Research Institute Inc.
- Methods of detection and removal of rhabdoviruses from cell lines30 Jul 2026US 2026/0217770 A1Takeda Vaccines, Inc.
- Methods of detection and removal of rhabdoviruses from cell lines3 Apr 2025US 2025/0109172 A1Takeda Vaccines, Inc.
- Chimeric pseudotyped recombinant rabies virus3 Oct 2024US 2024/0327802 A1Beam Therapeutics Inc.
- Methods of detection and removal of rhabdoviruses from cell lines28 Sep 2023US 2023/0303633 A1Takeda Vaccines, Inc.
- Compositions and methods for glioblastoma treatment21 Sep 2023US 2023/0293668 A1Children's Hospital of Eastern Ontario Research Institute Inc.
Most cited
By later US patents
- Methods for making modified recombinant vesiculoviruses51US 6,168,943 AYale University · 2001
- Recombinant vesiculoviruses and their uses39US 7,153,510 B1Yale University · 2006
- Oncolytic rhabdovirus6US 9,045,729 B2Children's Hospital of Eastern Ontario Research Institute Inc. · 2015
- Methods of detection and removal of rhabdoviruses from cell lines4US 10,501,500 B2Takeda Vaccines, Inc. · 2019
- Methods of detection and removal of rhabdoviruses from cell lines3US 11,286,282 B2Takeda Vaccines, Inc. · 2022